• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Kaiser To Fund Gun Injury Research


Three research studies will focus on how clinicians can help prevent firearm injuries.


Kaiser Permanente, the nation's largest nonprofit, integrated health system, will fund three clinical research studies related to gun injury research.

The clinical research studies that focus on how clinicians can help prevent firearm injuries, including suicide, intimate partner violence, and accidents, as part of its pledge to invest $2 million to prevent gun injuries and deaths.

The studies will be led by investigators at three of Kaiser Permanente's regional research institutes in partnership with its Permanente Medical Group clinicians and physicians.

The studies are:

  • Understanding Risk Factors of Firearm-related Injuries and Death in Adult and Pediatric Populations: Risk Prediction and Opportunities for Prevention. This study builds on existing work in Kaiser Permanente Washington that involves screening patients who are receiving mental health-related care for access to firearms.

Related: Surprising Perceptions About Mental Health

  • Evaluating a Web-Based Education Tool for Safe Firearm Storage in Patients at Risk for Suicide. This study will focus on patients who report suicidality during medical or mental health visits. It will test the impact of an anonymous, web-based decision aid for safe firearm storage as an adjunctive approach to existing provider-delivered interventions.

  •  Understanding Risk Factors of Firearm-related Injuries and Death in Adult and Pediatric Populations: Risk Prediction and Opportunities for Prevention. This study will develop a risk prediction model for both intentional and unintentional firearm-related injuries leveraging data from Kaiser Permanente Southern California and community-level data. It will also generate a heatmap of high-risk communities to inform strategies for firearm injury prevention interventions at the medical center and clinic level.

In 2018, Kaiser Permanente announced the formation of its Firearm Injury Prevention Task Force and an accompanying $2 million research fund to address preventable gun-related injuries and death.

Related Videos
Video 3 - "In-Office Procedures, Over-the-Counter Options, Treatment Delays, and Costs"
Video 6 - "Safety Analysis and Interpreting Results from MAJIC-PV"
Video 5 - "Key Findings from MAJIC-PV"
Video 2 - "Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%"
Gabriela Hobbs, MD, an expert on polycythemia vera
Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Related Content
© 2024 MJH Life Sciences

All rights reserved.